Life Science Technology News

09 February 2007 - GSK moves closer to flu pandemic preparedness with European filing

The European Committee for Medicinal Products for Human Use (CHMP) has accepted GlaxoSmithKline's new generation H5N1 split antigen pre-pandemic flu..  More >>

11 November 2005 - Process improvement can drive down the production cost of biopharmaceuticals

MorphoSys and Wacker show high yield expression of antibody fragments Modern protein biopharmaceuticals, for example derived from antibodies,..  More >>

26 February 2005 - Breakthrough for Avidex & Anosys in transatlantic deal to develop cancer vaccine

Outcome, "a significant milestone" in validating the expression of T-cell antigens to develop therapeutic vaccines with a broader potential application in..  More >>

18 November 2004 - Magnetotherapy: UK teams join forces to target cancer

Celltech collaborates with University of Durham and Oxford Instruments to pioneer new magnetotherapy technology The dream of a ’magic bullet’ approach to..  More >>

16 June 2003 - Metabolic target identified in type 2 diabetes and obesity research

Xcellsyz reports mode of action for new antidiabetic at the Amercian Diabetes Association meeting "Systems Biology used to identify target as GSK3" Xcellsyz..  More >>

11 June 2003 - Model mouse trap shrinks advanced cancerous tumors

Regeneron’s VEGF trap causes shrinkage of established tumors and metastases in preclinical studies Regeneron Pharmaceuticals, Inc. has reported that teams of..  More >>

06 June 2003 - API Development - CoFactor for advanced colorectal cancer trial goes into production

Biokeys Pharmaceuticals, Inc. starts manufacturing colorectal cancer agent for Phase II human trials San Diego, CA, based biopharma company Biokeys..  More >>

06 June 2003 - Arsenic and lace with Vitamin C for 'highly active' melphalan cocktail in resistant multiple myeloma

Trisenox® is highly active in refractory multiple myeloma patients when combined with Vitamin C and melphalan According to Cell Therapeutics, Inc., which..  More >>

05 June 2003 - Biopartnering opportunity: Oxford's novel anti-retroviral discovery platform

  Researchers at Oxford University’s Sir William Dunn School of Pathology in the UK develop a novel HTS for identifying antiretroviral (HIV)..  More >>

26 May 2003 - Business angels back bone transplant material development with £250K

Orthogem Ltd has raised £250,000 to develop its synthetic bone graft material. A substantial chunk of the new finance came from business angel investors in..  More >>

05 May 2003 - Scottish biotech cracks bovine virus detection with novel assay

Q-One Biotech develops novel infectivity assay for bovine polyomavirus Scientists working in Q-One Biotech’s expert virology R&D team at Glagow..  More >>

30 April 2003 - Inpharmatica in drug discovery deal with Galapagos Genomics

Inpharmatica and Galapagos Genomics to collaborate in therapeutics discovery Inpharmatica Ltd based in London, UK and Galapagos Genomics NV, the Belgian..  More >>